Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
The effectiveness of mifepristone, onapristone, and ORG 31806 alone or in combination with anordiol to terminate pregnancy in the rat was evaluated. ORG 31806 at a dose of 2 mg/kg/day, mifepristone at 4 mg/kg/day, and onapristone at 8 mg/kg/day, terminated pregnancy in all treated animals. Anordiol, an antiestrogen, at a dose of 5 mg/kg/day, terminated pregnancy in all treated animals. Anordiol acted synergistically with all three antiprogestins terminating pregnancy in the rat. The antiprogestins at doses that were either partially effective or non-effective became 100% effective when administered with a non-effective dose of anordiol. Thus, combination of ORG 31806 (1 mg/kg/day) plus anordiol (0.31 mg/kg/ day), mifepristone (1 mg/kg/day) plus anordiol (0.62 mg/ kg/day), and onapristone (2 mg/kg/day) plus anordiol (2.5 mg/kg/day) terminated pregnancy in all treated animals. These combinations of the antiprogestins and anordiol decreased significantly the serum progesterone levels but not serum 17 beta-estradiol levels. The present results indicate that the most potent combination was ORG 31806 plus anordiol.
Dao
B
B
Center for Biomedical Research, Population Council, New York, NY 10021, USA.
Vanage
G
G
Li
X J
XJ
Bardin
C W
CW
Koide
S S
SS
D000028:Abortion, Induced / Q000379:methods*; D000284:Administration, Oral; D000818:Animals; D015331:Cohort Studies; D003281:Contraceptives, Postcoital / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004357:Drug Synergism; D004958:Estradiol / Q000097:blood / Q000378:metabolism; D004963:Estrenes / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005663:Furans / Q000008:administration & dosage / Q000494:pharmacology*; D006067:Gonanes / Q000008:administration & dosage / Q000494:pharmacology*; D006727:Hormone Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D015735:Mifepristone / Q000008:administration & dosage / Q000494:pharmacology*; D009635:Norandrostanes / Q000008:administration & dosage / Q000494:pharmacology*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D003281:Contraceptives, Postcoital; D004338:Drug Combinations; D004963:Estrenes; D005663:Furans; D006067:Gonanes; D006727:Hormone Antagonists; D009635:Norandrostanes; C076197:Org 31806; D015735:Mifepristone; D011374:Progesterone; D004958:Estradiol; C023615:anordiol; C053238:onapristone